Overview
- An assessment at University Hospital Frankfurt found no new metastases and no growth of existing ones, which the family called a partial success.
- In two to three weeks, Delani is scheduled to return to University Hospital Würzburg for another radioisotope treatment, with the visit set for February 11.
- The oral component of the plan includes belzutifan, which the family says costs €17,830 per month on a private prescription with only partial reimbursement.
- After the four-week tablet cycle, immunotherapy infusions are planned in Frankfurt every three weeks for a few months until the next CT scan.
- Delani, 15, was diagnosed in early 2025 with an adrenal-region tumor that spread to her lungs after prior chemotherapies failed, and the family has continued treatment and fundraising after a palliative recommendation in Heidelberg, with €119,685 reported raised by January 27.